Everolimus therapy for severe left ventricular outflow tract obstruction in tuberous sclerosis complex: a fetal diagnosis and early neonatal management
Publication date: September–October 2026 Source: Progress in Pediatric Cardiology, Volume 84 Author(s): Ana Raquel Marques, Ana Correia-Costa, João Antunes Sarmento, Mafalda Sampaio, Ana Vilan, Carla Ramalho, Sofia Granja
Everolimus therapy for severe left ventricular outflow tract obstruction in tuberous sclerosis complex: a fetal diagnosis and early neonatal management. // Progress in Pediatric Cardiology. – URL: https://www.sciencedirect.com/science/article/pii/S1058981326000287?dgcid=rss_sd_all
Everolimus therapy for severe left ventricular outflow tract obstruction in tuberous sclerosis complex: a fetal diagnosis and early neonatal management. Progress in Pediatric Cardiology. https://www.sciencedirect.com/science/article/pii/S1058981326000287?dgcid=rss_sd_all
“Everolimus therapy for severe left ventricular outflow tract obstruction in tuberous sclerosis complex: a fetal diagnosis and early neonatal management.” Progress in Pediatric Cardiology.
@article{article62982,
title = {Everolimus therapy for severe left ventricular outflow tract obstruction in tuberous sclerosis complex: a fetal diagnosis and early neonatal management},
journal = {Progress in Pediatric Cardiology},
url = {https://www.sciencedirect.com/science/article/pii/S1058981326000287?dgcid=rss_sd_all}
}
ABSTRACT Aim To investigate the longitudinal association between early‐life movement behaviour patterns and later clinically diagnosed obesity. Method In the population‐based All Babies in Southeast Sweden (ABIS) cohort, 16 415 children...